Fatal intracranial hemorrhage following administration of recombinant thrombomodulin in a patient after cord blood transplantation

Bone Marrow Transplantation

Volumn 46, Issue 7, 2011, Pages 1030-1031

  Tsubokura, M ^a   Yamashita, T ^a   Inagaki, L ^a   Kobayashi, T ^a   Kakihana, K ^a   Wakabayashi, S ^a   Ohashi, K ^a   Ikezoe, T ^b   Asakura, H ^c   Koyama, T ^d   Tanimoto, T ^e   Kami, M ^f   Sakamaki, H ^a   Akiyama, H ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b KOCHI UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e CANCER INSTITUTE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III CONCENTRATE; BILIRUBIN; CYCLOPHOSPHAMIDE; FLUDARABINE; METHOTREXATE; RECOMBINANT THROMBOMODULIN; TACROLIMUS;

ABDOMINAL TENDERNESS; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ASCITES; BILIRUBIN BLOOD LEVEL; BRAIN HERNIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG SAFETY; ECHOGRAPHY; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEPATOMEGALY; HLA MATCHING; HUMAN; LETTER; LIVER VEIN OBSTRUCTION; MALE; OUTCOME ASSESSMENT; POOR GENERAL CONDITION; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SINUSOIDAL OBSTRUCTION SYNDROME; SUBARACHNOID HEMORRHAGE; THROMBOCYTE TRANSFUSION;

CORD BLOOD STEM CELL TRANSPLANTATION; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; THROMBOMODULIN;

EID: 79960154116     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.229     Document Type: Letter

References (8)

1. Maruyama I. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation. Thromb Haemost 1999; 82: 718-721.
2. Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 2007; 5: 31-41. (Pubitemid 44921064)
3. Ikezoe T, Togitani K, Komatsu N, Isaka M, Yokoyama A. Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin. Bone Marrow Transplant 2010; 45: 783-785.
4. Sakai M, Ikezoe T, Bandobashi K, Togitani K, Yokoyama A. Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin. Bone Marrow Transplant 2010; 45: 803-805.
5. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984;4:116-122. (Pubitemid 14185436)
6. Najima Y, Ohashi K, Miyazawa M, Nakano M, Kobayashi T, Yamashita T, et al. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation. Am J Hematol 2009; 84: 298-301.
7. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009; 145: 24-33.
8. Ho VT, Revta C, Richardson PG. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplant 2008; 41: 229-237. (Pubitemid 351260376)